ANGIOFOX 50 MG BIPHASIC (?ISOSORBIDE – 5 – MONONITRATE )?20 PROLONGED RELEASE CAPSULES

Angiofox Biphasic 25, 50 mg Capsules

Isosorbide-5-mononitrate 50 mg for the management of coronary aretry disease. In biphasic release formulation, 30% immediate release & 70% sustained release to provide risk adjusted protection with once daily dosage and nitrate free interval.

Composition

Isosorbide 5-mononitrate 50 mg in biphasic release formulation, 30% immediate release & 70% sustained release for risk adjusted protection.

Indications

Long term treatment of coronary artery disease. Prophylaxis of anginal attacks; post-treatment of myocardial infarction with persisting anginal symptoms; long term treatment of chronic congestive heart failure in combination with digitalis and/or diuretics; chronic cor pulmonale.

Side Effects

Headache (less frequent than with others) & subsides gradually upon continuing treatment).

Dosage and Administration

One to two capsules once daily.